People with hypoparathyroidism after surgical removal of the thyroid may develop calcium-alkali syndrome (CAS) — particularly if they are given high doses of vitamin D as a part of post-surgical care, a new study suggests. These findings highlight a need for routine surveillance of calcium levels following thyroid…
News
People with type 2 diabetes mellitus and muscle pain should have the calcium levels in their blood measured to check for hypoparathyroidism, a case report suggests. The study, “Type 2 diabetes mellitus complicated with idiopathic hypoparathyroidism where poor glycaemic control was associated with low adherence…
People with uncontrolled chronic hypoparathyroidism may more effectively manage their condition by taking oral calcium supplements every other day instead of daily, new research suggests. This finding was reported in “Alternate-day calcium dosing may be an effective treatment option for chronic hypoparathyroidism,” a study published in the…
Hypoparathyroidism may be the underlying cause of movement disorders, such as chorea, that are associated with calcium deposits in the brain, a case study reports. In patients with such motor problems and brain calcifications but no other neurological signs, doctors should strongly consider hypoparathyroidism, the researchers said.
Lower levels of parathyroid hormone (PTH) in people with hypoparathyroidism may lead to decreased bone material strength and increase the risk of fractures, a new study reports. The study, “PTH and bone material strength in hypoparathyroidism as measured by impact microindentation,” was published in the journal…
Rare Case of Calcium Supplements Risking Kidney Injury in Women with Hypoparathyroidism Reported
A 61-year-old woman’s case calls attention to the potential development of calcium-alkali syndrome (CAS) — a condition that can damage the kidneys — due to taking too many calcium and vitamin D supplements to treat hypoparathyroidism. Although such cases are rare, it is important to raise awareness for…
Despite skyrocketing healthcare costs, President Trump is committed to protecting the 30 million or so Americans with rare diseases and ensuring timely, affordable access to lifesaving treatments, the nation’s highest-ranking health official said. “We have to think about how our financing system can protect those with serious and rare illnesses.
Clinicians should consider the possibility of hypoparathyroidism in patients with chronic low levels of calcium, recurrent twitching of hands or feet, and even epileptic-like psychiatric symptoms to ensure early diagnosis and treatment, a case study reports. The study, “Hypoparathyroidism with Fahr’s syndrome: A case report and review…
Most people with uncontrolled, chronic hypoparathyroidism experience moderate-to-severe symptoms — even while on treatment — that lower their health-related quality of life (HRQoL), worsen their health status, and impact their ability to exercise or work, the results of a global survey show. The survey also found that greater symptom…
Phase 2 Trial of TransCon PTH to Speed Enrollment of Patients Affected by U.S. Recall of Natpara
A Phase 2 trial testing the experimental therapy TransCon PTH in adults with hypoparathyroidism is expanding to allow for faster enrollment of people previously treated with Natpara (parathyroid hormone, PTH), which was recently recalled in the United States. Developed by Ascendis Pharma, TransCon PTH is intended to restore…
Recent Posts
- Exploring possible causes of my chronic pain outside of hypopara
- Study highlights need to protect heart, kidney in hypoparathyroidism patients
- Reflecting on the qualities of a good friend in life with chronic illness
- New 5-tier system aims to better guide hypoparathyroidism treatment
- Reflections on gratitude and hope for the new year